Information updates

Update on supply of venom immunotherapy products in Australia and New Zealand

5 May 2018

As previously communicated, events overseas have impacted the ability of Stallergenes Greer to supply venom immunotherapy products to Australia and New Zealand. Stallergenes Greer has now advised ASCIA of the following supply update.

Honey Bee venom

  • Hymenoptera Honey Bee venom is now available in Australia. Please note that only orders for the “Hymenoptera” brand of honey bee venom will be processed at this time. Customers with backorders for the “Albey” brand honey bee venom are advised to contact their wholesaler and request these orders be changed to “Hymenoptera” or cancelled as appropriate. For any assistance, please contact the Stallergenes Greer Customer Service team on 1800 824 166 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
  • In New Zealand, Albey Honey Bee venom remains in stock.

Paper Wasp venom

  • Paper Wasp venom is currently out of stock in Australia. Stallergenes Greer is endeavouring to confirm the date of the next available shipment of Paper Wasp venom and will provide updates as soon as possible.
  • In New Zealand, Albey Paper Wasp venom remains in stock.

Yellow Jacket venom

  • The remaining inventory of Albey Yellow Jacket venom stock in Australia and New Zealand has now expired (expiry May 2018). Hymenoptera Yellow Jacket venom will be available in both Australia and New Zealand from mid-May 2018. Please note that Stallergenes Greer is actively working with the PBAC and Pharmac to ensure that Hymenoptera Yellow Jacket venom is listed and available under reimbursement to patients as soon as possible. They will advise once they have a confirmed listing date for both countries.

For further assistance, please contact Stallergenes Greer as follows:

  • For orders or status of orders, contact the Customer Service team on 1800 824 166 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
  • For medical information enquiries, contact Dr Martin Rees (APAC Regional Medical Director) by email at This email address is being protected from spambots. You need JavaScript enabled to view it.  
  • To report adverse events, contact Stallergenes Greer on 1800 824 166

Stallergenes Greer understands the impact of venom shortages on both patients and prescribers, and are committed to ensuring reliable supply of these important products into Australia and New Zealand on an ongoing basis.


They will provide further updates to the ASCIA community as soon as more information is available.

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.